|
1
|
de Alava E and Gerald WL: Molecular
biology of the Ewing's sarcoma/primitive neuroectodermal tumor
family. J Clin Oncol. 18:204–213. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mani S, Dutta D and De BK: Primitive
neuroectodermal tumor of the liver: A case report. Jpn J Clin
Oncol. 40:258–262. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Seemayer TA, Thelmo WL, Bolande RP and
Wiglesworth FW: Peripheral neuroectodermal tumors. Perspect Pediatr
Pathol. 2:151–152. 1975.PubMed/NCBI
|
|
4
|
Parham DM, Roloson GJ, Feely M, Green DM,
Bridge JA and Beckwith JB: Primary malignant neuroepithelial tumors
of the kidney: A clinicopathologic analysis of 146 adult and
pediatric cases from the National Wilms' Tumor Study Group
Pathology Center. Am J Surg Pathol. 25:133–146. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thyavihally YB, Tongaonkar HB, Gupta S,
Kurkure PA, Amare P, Muckaden MA and Desai SB: Primitive
neuroectodermal tumor of the kidney: A single institute series of
16 patients. Urology. 71:292–296. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chu WC, Reznikov B, Lee EY, Grant RM,
Cheng FW and Babyn P: Primitive neuroectodermal tumour (PNET) of
the kidney: A rare renal tumour in adolescents with seemingly
characteristic radiological features. Pediatr Radiol. 38:1089–1094.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim JS, Chung IS, Lim SH, Park Y, Park MJ,
Kim JY, Kim YG, Hong JT, Kim Y and Han SB: Preclinical and clinical
studies on cytokine-induced killer cells for the treatment of renal
cell carcinoma. Arch Pharm Res. 37:559–566. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li H, Yu JP, Cao S, Wei F, Zhang P, An XM,
Huang ZT and Ren XB: CD4+CD25+ regulatory T cells decreased the
antitumor activity of cytokine-induced killer (CIK) cells of lung
cancer patients. J Clin Immunol. 27:317–326. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu L, Zhang W, Qi X, Li H, Yu J, Wei S,
Hao X and Ren X: Randomized study of autologous cytokine-induced
killer cell immunotherapy in metastatic renal carcinoma. Clin
Cancer Res. 18:1751–1759. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartholow T and Parwani A: Renal primitive
neuroectodermal tumors. Arch Pathol Lab Med. 136:686–690. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ellinger J, Bastian PJ, Hauser S, Biermann
K and Müller SC: Primitive neuroectodermal tumor: Rare, highly
aggressive differential diagnosis in urologic malignancies.
Urology. 68:257–262. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lam JS, Hensle TW, Delbelenko L,
Granowetter L and Tennenbaum SY: Organ confined primitive
neuroectodermal tumour arising from the kidney. J Pediatr Surg.
38:619–621. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rodríguez-Galindo C, Liu T, Krasin MJ, Wu
J, Billups CA, Daw NC, Spunt SL, Rao BN, Santana VM and Navid F:
Analysis of prognostic factors in ewing sarcoma family of tumors:
Review of St. Jude Children's Research Hospital Studies. Cancer.
110:375–384. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ellison DA, Parham DM, Bridge J and
Beckwith JB: Immunohistochemistry of primary malignant
neuroepithelial tumors of the kidney: A potential source of
confusion? A study of 30 cases from the national Wilm's tumor study
pathology center. Hum Pathol. 38:205–211. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wada Y, Yamaguchi T, Kuwahara T, Sugiyama
Y, Kikukawa H and Ueda S: Primitive neuroectodermal tumour of the
kidney with spontaneous regression of pulmonary metastases after
nephrectomy. BJU Int. 91:121–122. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ravindra S and Kini U: Cytomorphology and
morphometry of small round-cell tumors in the region of the kidney.
Diagn Cytopathol. 32:211–216. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Risi E, Iacovelli R, Altavilla A, Alesini
D, Palazzo A, Mosillo C, Trenta P and Cortesi E: Clinical and
pathological features of primary neuroectodermal tumor/Ewing
sarcoma of the kidney. Urology. 82:382–386. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kumar R, Gautam U, Srinivasan R, Lal A,
Sharma U, Nijhawan R and Kumar S: Primary Ewing's sarcoma/primitive
neuroectodermal tumor of the kidney: Report of a case diagnosed by
fine needle aspiration cytology and confirmed by
immunocytochemistry and RT-PCR along with review of literature.
Diagn Cytopathol. 40 Suppl 2:E156–E161. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schmidt-Wolf IG, Finke S, Trojaneck B,
Denkena A, Lefterova P, Schwella N, Heuft HG, Prange G, Korte M,
Takeya M, et al: Phase I clinical study applying autologous
immunological effector cells transfected with the interleukin-2
gene in patients with metastatic renal cancer, colorectal cancer
and lymphoma. Br J Cancer. 81:1009–1016. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jäkel CE, Hauser S, Rogenhofer S, Müller
SC, Brossart P and Schmidt-Wolf IG: Clinical studies applying
cytokine-induced killer cells for the treatment of renal cell
carcinoma. Clin Dev Immunol. 2012:4732452012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pievani A, Borleri G, Pende D, Moretta L,
Rambaldi A, Golay J and Introna M: Dual-functional capability of
CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and
retains TCR-mediated specific cytotoxicity. Blood. 118:3301–3310.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Girardi M, Oppenheim DE, Steele CR, Lewis
JM, Glusac E, Filler R, Hobby P, Sutton B, Tigelaar RE and Hayday
AC: Regulation of cutaneous malignancy by gammadelta T cells.
Science. 294:605–609. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Karimi M, Cao TM, Baker JA, Verneris MR,
Soares L and Negrin RS: Silencing human NKG2D, DAP10 and DAP12
reduces cytotoxicity of activated CD8+ T cells and NK cells. J
Immunol. 175:7819–7828. 2005. View Article : Google Scholar : PubMed/NCBI
|
